News Sartorius Stedim Biotech S.A. OTC Markets

Equities

SRTOY

US80386Y1010

Market Closed - OTC Markets Other stock markets 14:01:27 2024-06-06 EDT			5-day change	1st Jan Change
20.64 ^USD	+0.68%		-2.87%	-24.75%

06-03	SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%)
05-16	Sartorius sinks again towards year low	DP

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%)	06-03
Sartorius Stedim Biotech Capital Markets: Links to presentation and webcast	05-17	EQ
Sartorius sinks again towards year low	05-16	DP
Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft - Analyst/Investor Day	05-16
Certain Shares of Sartorius Stedim Biotech S.A. are subject to a Lock-Up Agreement Ending on 8-MAY-2024.	05-07	CI
SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating	04-23	ZD
Sartorius Stedim: in the red with brokerage comments	04-22	CF
UBS Cuts Sartorius Stedim Biotech PT, Maintains at Neutral	04-22	MT
SARTORIUS STEDIM BIOTECH : Q1 24: A few positives despite the top-line miss	04-22
SARTORIUS STEDIM : UBS reduces target price	04-22	CF
Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix...	04-18
Transcript : Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	04-18
Transcript : Sartorius Aktiengesellschaft, Sartorius Stedim Biotech S.A., Q1 2024 Earnings Call, Apr 18, 2024	04-18
Sartorius and subsidiary Stedim under pressure after weak figures	04-18	DP
Sartorius Stedim: Quarterly EPS more than halved	04-18	CF
Sartorius Stedim Biotech S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-18	CI
Sartorius Stedim Biotech Records Lower Q1 Attributable Net Profit, Sales Revenue	04-18	MT
Sartorius Stedim Biotech publishes unaudited first quarter results for 2024	04-18	EQ
Ex-dividend day for final dividend	04-01	FA
Resolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.	03-26	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SARTORIUS STEDIM BIOTECH : EPS cut (2023: -13.7%, 2024: -16.4%)

June 03, 2024 at 03:32 am